Euroapi PEG

Cosa fa Euroapi? Euroapi SA, listed on EAPI.PA with ISIN FR0014008VX5, is a pharmaceutical company headquartered in Paris, France. The company went public on May 6, 2022, and currently employs 3,449 full-time staff. Euroapi specializes in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) for healthcare partners. Its product portfolio includes vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids, hormones, anti-infectives, opiates such as morphine, codeine, and thebaine, and analgesics. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering services such as Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones, and Opiates & Controlled Substances. Euroapi maintains production facilities across multiple European countries, including France, the United Kingdom, Germany, Italy, and Hungary. The company's website is www.euroapi.com, where further information about its services and operations can be found. Euroapi focuses on providing tailored API solutions to support the pharmaceutical industry's needs, emphasizing its role in the healthcare sector through its specialized manufacturing capabilities. Euroapi è una delle aziende più popolari su Eulerpool.com.